Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Rhythm Pharmaceuticals, Inc.

RYTM

Valuace

Růst

Zdraví

Cena

$ 88.73

-4.43 (-4.18%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Total Revenues	189.8	189.8	130.1	77.4	23.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of Revenues	19.5	19.5	13.4	9.3	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross Profit	170.3	170.3	116.8	68.1	21.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	57.3	51.3	48.5	32.7	41.8	33.3	29.1	26.0	24.2	22.5
Cost of Revenues	4.8	5.5	5.5	3.6	3.8	3.8	2.9	2.8	3.2	2.4
Gross Profit	52.5	45.8	43.0	29.1	38.0	29.4	26.1	23.2	21.0	20.1

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
R&D Expenses	0.0	0.0	0.0	135.0	108.6	104.1	90.5	109.5	50.3	22.9	19.6	7.1	18.0	15.7
Selling General & Admin Expenses	0.0	0.0	0.0	117.5	92.0	68.5	46.1	36.6	28.1	9.5	6.3	3.4	3.4	2.5
Depreciation & Amortization	1.3	1.3	1.6	1.8	3.2	1.2	0.7	0.8	0.4	0.2	0.1	0.5	0.0	0.0
Total Operating Expenses	362.3	362.3	382.3	252.5	200.7	172.6	136.6	146.0	78.4	32.4	25.9	10.6	21.4	18.1
Operating Income	-192.0	-192.0	-265.5	-184.4	-179.2	-170.1	-136.6	-146.0	-78.4	-32.4	-25.9	-10.6	-21.4	-18.1

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	33.6
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	30.5
Depreciation & Amortization	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5
Total Operating Expenses	99.5	98.5	88.3	76.1	79.3	73.3	66.6	163.0	62.3	64.0
Operating Income	-47.1	-52.7	-45.3	-47.0	-41.3	-43.9	-40.5	-139.9	-41.3	-44.0

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Interest Income	15.3	15.3	14.7	13.9	4.0	0.4	2.6	5.3	4.4	0.6	0.0	0.0	0.0	0.0
Interest Expense	20.6	20.6	20.6	13.9	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Expense	-4.0	-4.0	5.2	0.2	-2.0	100.4	2.6	5.3	4.4	-1.9	0.0	-0.5	0.0	0.0
IBT	-196.0	-196.0	-260.3	-184.1	-181.1	-69.6	-134.0	-140.7	-74.1	-33.7	-25.9	-11.1	-21.4	-18.1
Income Tax Expense	0.5	0.5	0.3	0.6	2.0	-1.6	-3.3	-6.1	4.4	1.1	0.0	0.0	0.0	0.0
Net Income	-196.5	-196.5	-260.6	-184.7	-183.1	-68.0	-130.7	-134.6	-74.1	-33.7	-25.9	-11.1	-21.4	-18.1

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	4.1	4.3	3.2	3.6	3.5	4.1	4.1	3.0	3.8	3.5
Interest Expense	4.6	4.7	5.8	5.4	5.4	5.2	4.6	4.8	4.6	3.1
Other Expense	-0.5	-0.1	-1.0	-2.4	-2.1	-0.1	8.7	-1.2	-0.2	0.2
IBT	-47.5	-52.8	-46.3	-49.4	-43.4	-44.0	-31.8	-141.1	-41.4	-43.8
Income Tax Expense	0.0	0.1	0.3	0.1	-0.1	-0.3	0.5	0.3	0.2	0.4
Net Income	-47.5	-52.9	-46.6	-49.5	-43.3	-43.6	-32.3	-141.4	-41.6	-44.2

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
EPS	$0.00	$0.00	$0.00	$-3.20	$-3.51	$-1.37	$-2.96	$-3.70	$-2.39	$-2.54	$-1.55	$-0.66	$-0.43	$-0.36
EPS Diluted	$0.00	$0.00	$0.00	$-3.20	$-3.51	$-1.37	$-2.96	$-3.70	$-2.39	$-2.54	$-1.55	$-0.66	$-0.43	$-0.36
Shares Outstanding	66.9	65.0	61.0	57.7	52.1	49.6	44.1	36.4	31.0	13.3	16.7	16.7	50.3	50.3
Diluted Shares Outstanding	66.9	65.0	61.0	57.7	52.1	49.6	44.1	36.4	31.0	13.3	16.7	16.7	50.3	50.3

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.70	$-0.76
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.70	$-0.76
Shares Outstanding	66.9	64.3	63.7	63.1	61.6	61.2	61.0	60.1	59.2	57.9
Diluted Shares Outstanding	66.9	64.3	63.7	63.1	61.6	61.2	61.0	60.1	59.2	57.9

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Cash And Equivalents	161.7	89.1	60.1	127.7	59.2	100.9	62.3	49.5	34.2	6.5	34.9	7.4	11.8
Short Term Investments	157.5	231.4	215.8	205.6	235.6	71.9	230.2	202.5	113.8	4.0	0.0	10.4	5.3
Total Cash & ST Investments	319.1	320.6	275.8	333.3	294.9	172.8	292.5	252.1	148.1	10.5	34.9	17.8	17.0
Accounts Receivable	17.6	18.5	14.9	6.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	12.0	18.7	8.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	8.6	16.4	8.9	11.8	12.5	8.9	9.9	6.6	2.6	0.2	0.0	0.4	1.8
Total Current Assets	357.4	374.2	308.3	354.2	308.4	181.7	302.4	258.7	150.7	11.2	35.5	18.1	18.9

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	52.1	135.6	106.1	89.1	47.5	161.7	53.4	60.1	64.6	115.7
Short Term Investments	364.0	155.4	208.4	231.4	250.9	157.5	147.8	215.8	234.7	137.9
Total Cash & ST Investments	416.1	291.0	314.5	320.6	298.4	319.1	201.2	275.8	299.3	253.6
Accounts Receivable	33.0	26.1	17.8	18.5	19.3	17.6	14.7	14.9	14.5	13.8
Inventory	0.0	18.9	19.3	18.7	13.9	12.0	8.5	8.6	7.8	6.2
Other Current Assets	45.7	24.7	17.7	16.4	8.8	8.6	11.4	8.9	7.6	10.3
Total Current Assets	494.8	360.7	369.3	374.2	340.3	357.4	235.8	308.3	329.2	283.9

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Net Property, Plant & Equipment	4.7	4.1	2.1	3.4	4.3	5.0	5.7	1.1	0.8	0.9	0.0	0.0	0.0
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	6.6	6.2	7.0	7.9	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	12.8	7.8	15.3	17.0	12.1	0.4	0.4	0.4	0.2	0.2	1.8	0.0	0.0
Total Long-Term Assets	24.5	18.1	24.5	28.2	21.1	5.4	6.1	1.5	1.1	1.2	1.8	0.0	0.1
Total Assets	381.8	392.3	332.7	382.5	329.5	187.1	308.5	260.2	151.7	12.3	37.3	18.2	18.9

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	0.0	3.6	3.8	4.1	4.4	4.7	1.8	2.1	2.4	2.8
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	5.5	5.7	6.0	6.2	6.4	6.6	6.8	7.0	7.2	7.5
Long-Term Investments	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3
Other Long-Term Assets	5.9	2.7	7.6	7.8	12.5	13.2	14.3	15.3	15.3	15.8
Total Long-Term Assets	12.1	12.1	17.4	18.1	23.2	24.5	22.9	24.5	25.0	26.1
Total Assets	506.9	372.7	386.7	392.3	363.6	381.8	258.7	332.7	354.2	309.9

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Accounts Payable	4.5	12.3	4.9	4.8	5.7	4.9	10.4	7.6	2.4	1.9	1.4	1.5	2.2
Short-Term Debt	0.8	0.0	1.5	0.7	0.6	0.5	0.5	0.0	0.0	0.0	3.6	0.0	0.0
Other Current Liabilities	48.1	101.9	47.5	32.9	30.1	0.2	0.4	5.9	4.3	2.8	0.0	1.6	0.3
Current Liabilities	54.7	115.5	55.2	39.8	43.4	18.0	24.4	13.6	6.7	4.7	5.3	3.1	2.5

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	13.6	16.0	11.9	12.3	4.9	4.5	7.6	4.9	3.8	8.4
Short-Term Debt	0.6	4.3	0.2	0.0	0.0	0.8	0.8	1.5	1.5	1.5
Other Current Liabilities	142.8	109.2	99.7	101.9	91.4	48.1	44.5	47.5	43.5	35.0
Current Liabilities	104.3	129.5	111.8	115.5	97.6	54.7	54.2	55.2	50.1	46.1

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Long-Term Debt	248.5	3.9	0.5	1.3	1.9	2.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0
Capital Leases	3.3	3.9	1.3	1.9	2.6	3.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	342.5	227.7	163.0	118.2	45.4	20.5	27.5	14.0	6.9	5.0	5.3	75.6	55.2

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	150.4	255.2	3.8	3.9	4.0	3.3	0.3	0.5	0.7	0.9
Capital Leases	4.1	4.2	4.1	3.9	4.0	3.3	0.3	1.3	1.4	1.6
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	358.1	384.6	223.6	227.7	210.9	202.4	197.1	163.0	156.7	127.7

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Common Stock	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
Retained Earnings	-1,068.4	-1,155.3	-894.7	-710.1	-528.9	-459.3	-325.3	-184.6	-110.3	-76.5	-50.7	-58.4	-37.0
Comprehensive Income	-0.6	0.0	0.1	-0.1	0.0	0.0	0.0	-0.8	-0.4	-0.1	0.0	0.0	0.0
Total Common Equity	39.3	164.5	169.8	264.3	284.2	166.5	281.0	246.3	144.8	7.3	32.0	-57.5	-36.3

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Retained Earnings	-1,304.4	-1,251.5	-1,204.8	-1,155.3	-1,112.0	-1,068.4	-1,036.1	-894.7	-853.1	-808.9
Comprehensive Income	-0.9	-2.2	-0.1	0.0	-0.6	-0.6	-0.2	0.1	-0.1	0.0
Total Common Equity	148.8	-11.9	163.1	164.5	152.7	179.5	61.6	169.8	197.5	182.3

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Total Debt		252.6	3.9	1.3	1.9	2.6	3.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		39.3	164.5	169.8	264.3	284.2	166.5	281.0	246.3	144.8	7.3	32.0	-57.5	-36.3

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		148.8	-11.9	163.1	164.5	152.7	179.5	61.6	169.8	197.5	182.3

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Net Income	-259.4	-196.5	-260.6	-184.7	-181.1	-69.6	-134.0	-140.7	-74.1	-33.7	-25.9	-11.1	-21.4	-18.1
Depreciation & Amortization	1.7	1.3	1.6	1.8	1.7	1.2	0.7	0.8	0.4	0.2	0.1	0.0	0.0	0.0
Stock-Based Compensation	35.4	66.8	39.7	32.6	19.8	20.8	17.5	11.9	6.4	2.3	1.2	0.3	0.0	0.0
Change Working Capital	7.4	-1.0	10.6	4.8	-19.7	1.9	-5.9	5.1	0.7	0.0	1.3	2.4	2.0	0.2
Change In Accounts Receivable	-3.8	-7.6	-3.6	-8.6	-5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Change In Accounts Payable	8.2	21.9	21.9	14.8	1.5	18.3	10.5	10.5	7.0	1.9	0.5	3.8	-0.8	1.6
Change In Inventories	-5.8	-7.5	-10.1	-5.7	-2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-cash Items	123.2	13.7	94.9	9.4	5.9	-0.3	-0.2	0.2	4.5	-0.1	0.0	1.4	0.3	0.1
Cash from Operations	-128.5	0.0	0.0	-136.2	-173.4	-146.0	-122.0	-122.8	-62.1	-29.5	-23.2	-7.0	-19.2	-17.8

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	-47.5	-52.9	-46.6	-49.5	-43.3	-43.6	-32.3	-141.4	-41.6	-44.2
Depreciation & Amortization	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4
Stock-Based Compensation	19.3	18.8	15.9	12.9	10.6	0.0	10.4	7.8	8.7	8.6
Change Working Capital	-0.7	3.1	4.5	-7.9	10.2	4.7	-2.1	-2.2	8.9	2.8
Change In Accounts Receivable	6.2	-6.6	-7.8	0.7	0.8	-1.7	-2.9	0.2	-0.3	-0.7
Change In Accounts Payable	1.3	11.0	13.3	-3.6	15.2	7.5	0.5	-1.3	4.9	4.1
Change In Inventories	-4.9	-2.5	0.5	-0.6	-4.8	-1.9	-3.5	0.1	-0.9	-1.6
Other Non-cash Items	3.3	4.1	2.5	3.8	3.3	13.3	-5.4	94.6	4.1	3.3
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-29.4	-29.3

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2013	2012
Capital Expenditure	-40.0	-1.0	0.0	0.0	-4.3	-5.4	-0.2	-3.4	-0.7	-0.1	-1.1	0.0	0.0
Acquisitions	-22.6	0.0	0.0	0.0	4.0	100.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments	-276.2	-348.7	-268.3	-354.9	-251.9	-525.0	-86.9	-295.8	-248.6	-126.9	-15.2	-28.7	-8.8
Sales of Investment	265.6	252.5	260.6	355.0	284.2	361.2	245.6	271.2	162.2	17.0	11.2	23.6	3.5
Other Investing Activities	-17.6	0.0	0.0	-5.7	-4.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash from Investing	-50.8	0.0	0.0	-5.7	28.0	-62.2	158.5	-28.0	-87.1	-110.0	-5.1	-5.1	-5.3

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-1.0	0.0	0.0	0.0	0.0	-0.5	0.0	-40.0	0.0	0.0
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-22.6	0.0
Investments	-20.3	-267.8	-27.0	-33.5	-66.4	-135.6	-66.3	0.0	-40.7	-169.2
Sales of Investment	51.6	61.5	81.0	58.3	87.5	45.3	57.8	70.1	63.3	74.5
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	-0.3
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	-95.0

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2015	2013	2012
Debt Repaid	-10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	261.5	3.9	2.7	-0.7	-0.6	-0.5	-0.5	3.6	0.0	0.0	0.0	0.0	0.0
Issuance of Common Stock	203.1	0.0	0.0	48.9	131.1	161.7	161.4	161.4	162.9	125.7	0.0	0.0	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	27.9	0.0	0.0	25.5	82.7	4.8	-159.3	2.1	1.8	41.5	41.7	19.9	22.4
Cash from Financing	225.9	0.0	0.0	74.4	213.8	166.5	2.0	163.5	164.7	167.2	41.7	19.9	22.4

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	151.0	-108.5	255.4	0.1	-0.1	-0.1	3.0	-0.2	-0.2	-0.2
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	50.8
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	73.0
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	73.0

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Net Change in Cash		46.0	-34.8	29.2	-67.6	68.4	-41.7	38.6	12.8	15.5	27.7	-28.3	34.7	-4.4	-0.7
Closing Cash Balance		161.7	54.8	89.6	60.4	128.0	59.6	101.3	62.7	49.9	34.2	6.5	34.9	7.4	11.8

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		2.1	-83.4	29.6	17.0	41.6	-114.1	108.2	-6.5	-4.5	-51.1
Closing Cash Balance		54.8	52.7	136.1	106.6	89.6	47.5	162.1	53.9	60.4	64.9

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012
Free Cash Flow		-168.5	-116.6	-113.9	-136.2	-177.7	-151.4	-122.2	-126.1	-62.8	-29.6	-24.3	-7.0	-19.2	-17.8
Real Free Cash Flow		-203.9	-183.4	-153.6	-168.8	-197.5	-172.2	-139.6	-138.0	-69.2	-31.9	-25.4	-7.3	-19.2	-17.8

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		-26.3	-26.6	-23.3	-40.4	-18.8	-25.2	-29.1	-80.7	-29.4	-29.3
Real Free Cash Flow		-45.6	-45.4	-39.2	-53.2	-29.4	-25.2	-39.4	-88.5	-38.1	-37.9